GT
EMN icon

Greenleaf Trust’s Eastman Chemical EMN Stock Holding History

Greenleaf Trust’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Sell
4,550
-3,514
-44% -$257K ﹤0.01% 689
2026
Q1 		$615K Buy
8,064
+58
+0.7% +$4.18K 0.01% 440
2025
Q4 		$511K Buy
8,006
+2,005
+33% +$124K ﹤0.01% 494
2025
Q3 		$378K Buy
6,001
+53
+0.9% +$3.7K ﹤0.01% 570
2025
Q2 		$444K Sell
5,948
-524
-8% -$41.2K ﹤0.01% 519
2025
Q1 		$570K Buy
6,472
+2
+0% +$189 0.01% 465
2024
Q4 		$591K Sell
6,470
-175
-3% -$17.9K 0.01% 471
2024
Q3 		$744K Buy
6,645
+128
+2% +$12.8K 0.01% 417
2024
Q2 		$638K Buy
6,517
+185
+3% +$18.4K 0.01% 415
2024
Q1 		$635K Sell
6,332
-143
-2% -$12.6K 0.01% 407
2023
Q4 		$582K Buy
6,475
+333
+5% +$26.5K 0.01% 416
2023
Q3 		$471K Sell
6,142
-358
-6% -$29.7K 0.01% 454
2023
Q2 		$544K Sell
6,500
-476
-7% -$38.7K 0.01% 431
2023
Q1 		$588K Buy
6,976
+409
+6% +$35.1K 0.01% 402
2022
Q4 		$535K Sell
6,567
-1,318
-17% -$106K 0.01% 427
2022
Q3 		$560K Buy
7,885
+793
+11% +$71.3K 0.01% 369
2022
Q2 		$637K Buy
7,092
+148
+2% +$15.3K 0.01% 328
2022
Q1 		$778K Sell
6,944
-708
-9% -$83K 0.01% 301
2021
Q4 		$925K Buy
7,652
+193
+3% +$21.5K 0.01% 264
2021
Q3 		$751K Sell
7,459
-126
-2% -$13.9K 0.01% 287
2021
Q2 		$886K Buy
7,585
+168
+2% +$20.2K 0.01% 250
2021
Q1 		$817K Buy
7,417
+3,758
+103% +$408K 0.01% 248
2020
Q4 		$367K Buy
3,659
+362
+11% +$33.6K ﹤0.01% 413
2020
Q3 		$258K Buy
3,297
+132
+4% +$9.95K ﹤0.01% 449
2020
Q2 		$220K Buy
+3,165
New +$199K ﹤0.01% 484
2019
Q1 		– Sell
-2,878
Closed -$210K – 535
2018
Q4 		$210K Buy
+2,878
New +$229K ﹤0.01% 440
2018
Q1 		– Sell
-345
Closed -$32K – 575
2017
Q4 		$32K Hold
345
– – ﹤0.01% 527
2017
Q3 		$31K Buy
+345
New +$29.4K ﹤0.01% 498

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Greenleaf Trust's EMN Position: Q2 2026 in Review

Greenleaf Trust reduced its Eastman Chemical (EMN) stake by 44% in Q2 2026, selling an estimated $257K and leaving 4,550 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Greenleaf Trust first reported a position in EMN in Q3 2017 and has held it in 28 quarters since. The position peaked at $925K in Q4 2021. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Greenleaf Trust held 4,550 shares of Eastman Chemical worth $305K as of Q2 2026.
  • Greenleaf Trust sold 3,514 Eastman Chemical shares in Q2 2026, an estimated $257K.
  • Eastman Chemical made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #689 holding.
  • Greenleaf Trust first reported a position in Eastman Chemical in Q3 2017 and has held it in 28 quarters since.
  • Greenleaf Trust's Eastman Chemical position peaked at $925K in Q4 2021.
  • 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.